Effects of pioglitazone on nonalcoholic steatohepatitis in a patient with anorexia nervosa: A case report

Ohno,Tomohiko; Nishigaki,Yoichi; Yamada,Tetsuya; Wakahara,Yuko; Sakai,Hiroyasu; Yoshimura,Kotaro; Shimizu,Masahito; Usui,Toshio; Saito,Masaya; Yasuda,Ichiro; Tsurumi,Hisashi; Tomita,Eiichi; Moriwaki,Hisataka

doi:10.3892/etm.2014.1509

Effects of pioglitazone on nonalcoholic steatohepatitis in a patient with anorexia nervosa: A case report

Authors:
- Tomohiko Ohno
- Yoichi Nishigaki
- Tetsuya Yamada
- Yuko Wakahara
- Hiroyasu Sakai
- Kotaro Yoshimura
- Masahito Shimizu
- Toshio Usui
- Masaya Saito
- Ichiro Yasuda
- Hisashi Tsurumi
- Eiichi Tomita
- Hisataka Moriwaki
View Affiliations

Affiliations: Department of Medicine, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan, Second Department of Internal Medicine, Gifu Municipal Hospital, Gifu 500-8513, Japan, Department of Clinical Laboratory, Gifu Municipal Hospital, Gifu 500-8513, Japan, Department of Internal Medicine, Seki Central Hospital, Gifu 500-3919, Japan
Published online on: January 28, 2014 https://doi.org/10.3892/etm.2014.1509
Pages: 811-815

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Diseases associated with metabolic syndromes are of major concern in developed countries. Nonalcoholic steatohepatitis (NASH) is one of the manifestations of metabolic syndrome in the liver. Previous studies have shown that NASH is also caused by malnutrition. In the present study, a case of malnutrition-associated NASH in a 66-year-old female with anorexia nervosa is reported. The patient had a body mass index (BMI) of only 11.1 kg/m2 and serum alanine aminotransferase levels of 1,495 IU/l. Steatohepatitis with fibrosis was confirmed by percutaneous liver needle biopsy. Total parenteral nutrition was conducted at first, followed by the administration of Stronger Neo‑Minophagen C (a glycyrrhizin-containing preparation), ursodeoxycholic acid and prednisolone. The abnormal elevation of aminotransferase levels of the patient was prolonged and total bilirubin levels increased. Pioglitazone (15 mg/day), which has been identified to be effective for nonalcoholic steatohepatitis, was then administered. This resulted in marked reductions in aminotransferase and bilirubin levels within three months. Histological improvement of the liver was also confirmed by percutaneous liver needle biopsy after one year. The observations in the present case suggest that pioglitazone may be useful for the treatment of malnutrition-associated NASH.

View Figures

View References

1	Lucas AR, Crowson CS, O’Fallon WM and Melton LJ III: The ups and downs of anorexia nervosa. Int J Eat Disord. 26:397–405. 1999. View Article : Google Scholar : PubMed/NCBI
2	Tomita K, Haga H, Ishii G, et al: Clinical manifestations of liver injury in patients with anorexia nervosa. Hepatol Res. July 11–2013.(Epub ahead of print).
3	Kuboki T, Nomura S, Ide M, Suematsu H and Araki S: Epidemiological data on anorexia nervosa in Japan. Psychiatry Res. 62:11–16. 1996. View Article : Google Scholar
4	Sakada M, Tanaka A, Ohta D, et al: Severe steatosis resulted from anorexia nervosa leading to fatal hepatic failure. J Gastroenterol. 41:714–715. 2006. View Article : Google Scholar : PubMed/NCBI
5	Ludwig J, Viggiano TR, McGill DB and Oh BJ: Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc. 55:434–438. 1980.PubMed/NCBI
6	Sanyal AJ; American Gastroenterological Association. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology. 123:1705–1725. 2002. View Article : Google Scholar : PubMed/NCBI
7	Rautou PE, Cazals-Hatem D, Moreau R, et al: Acute liver cell damage in patients with anorexia nervosa: a possible role of starvation-induced hepatocyte autophagy. Gastroenterology. 135:840–848. 2008. View Article : Google Scholar : PubMed/NCBI
8	Narayanan V, Gaudiani JL, Harris RH and Mehler PS: Liver function test abnormalities in anorexia nervosa - cause or effect. Int J Eat Disord. 43:378–381. 2010.PubMed/NCBI
9	Dowman J, Arulraj R and Chesner I: Recurrent acute hepatic dysfunction in severe anorexia nervosa. Int J Eat Disord. 43:770–772. 2010. View Article : Google Scholar : PubMed/NCBI
10	Promrat K, Kleiner DE, Niemeier HM, et al: Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology. 51:121–129. 2010. View Article : Google Scholar : PubMed/NCBI
11	Belfort R, Harrison SA, Brown K, et al: A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N Engl J Med. 355:2297–2307. 2006. View Article : Google Scholar : PubMed/NCBI
12	Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC and McCullough AJ: Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 116:1413–1419. 1999. View Article : Google Scholar : PubMed/NCBI
13	Seidell JC: Obesity, insulin resistance and diabetes - a worldwide epidemic. Br J Nutr. 83(Suppl 1): S5–S8. 2000. View Article : Google Scholar : PubMed/NCBI
14	Smink FR, van Hoeken D and Hoek HW: Epidemiology of eating disorders: incidence, prevalence and mortality rates. Curr Psychiatry Rep. 14:406–414. 2012. View Article : Google Scholar : PubMed/NCBI
15	Osifo BO and Bolodeoku JO: Serum aspartate and alanine aminotransferase activities in protein energy malnutrition. Enzyme. 28:300–304. 1982.PubMed/NCBI
16	Meinhardt NG, Souto KE, Ulbrich-Kulczynski JM and Stein AT: Hepatic outcomes after jejunoileal bypass: is there a publication bias? Obes Surg. 16:1171–1178. 2006. View Article : Google Scholar : PubMed/NCBI
17	Suzaki A, Miura H, Takazoe M, Hamada T and Kitamura S: Nonalcoholic steatohepatitis due to Crohn disease: a lethal case report. Nihon Shokakibyo Gakkai Zasshi. 100:1212–1218. 2003.(In Japanese).
18	Furuta S, Ozawa Y, Maejima K, et al: Anorexia nervosa with severe liver dysfunction and subsequent critical complications. Intern Med. 38:575–579. 1999. View Article : Google Scholar : PubMed/NCBI
19	Aithal GP, Thomas JA, Kaye PV, et al: Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis. Gastroenterology. 135:1176–1184. 2008. View Article : Google Scholar : PubMed/NCBI
20	Tomita K, Azuma T, Kitamura N, et al: Pioglitazone prevents alcohol-induced fatty liver in rats through up-regulation of c-Met. Gastroenterology. 126:873–885. 2004. View Article : Google Scholar : PubMed/NCBI
21	Hallakou S, Doaré L, Foufelle F, et al: Pioglitazone induces in vivo adipocyte differentiation in the obese Zucker fa/fa rat. Diabetes. 46:1393–1399. 1997. View Article : Google Scholar : PubMed/NCBI
22	Kletzien RF, Clarke SD and Ulrich RG: Enhancement of adipocyte differentiation by an insulin-sensitizing agent. Mol Pharmacol. 41:393–398. 1992.PubMed/NCBI
23	Laplante M, Festuccia WT, Soucy G, et al: Mechanisms of the depot specificity of peroxisome proliferator-activated receptor gamma action on adipose tissue metabolism. Diabetes. 55:2771–2778. 2006. View Article : Google Scholar
24	Watkins PB: Idiosyncratic liver injury: challenges and approaches. Toxicol Pathol. 33:1–5. 2005. View Article : Google Scholar : PubMed/NCBI
25	Wang H, Khaoustov VI, Krishnan B, et al: Total parenteral nutrition induces liver steatosis and apoptosis in neonatal piglets. J Nutr. 136:2547–2552. 2006.PubMed/NCBI
26	Matsumoto T, Yamasaki S, Arakawa A, et al: Exposure to a high total dosage of glucocorticoids produces non-alcoholic steatohepatits. Pathol Int. 57:388–389. 2007. View Article : Google Scholar : PubMed/NCBI
27	Leuschner UF, Lindenthal B, Herrmann G, et al: High-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double-blind, randomized, placebo-controlled trial. Hepatology. 52:472–479. 2010. View Article : Google Scholar : PubMed/NCBI
28	Tobari M, Hashimoto E, Yatsuji S, Torii N and Shiratori K: Imaging of nonalcoholic steatohepatitis: advantages and pitfalls of ultrasonography and computed tomography. Intern Med. 48:739–746. 2009. View Article : Google Scholar : PubMed/NCBI